CR
Christine Ring (Chief Legal Officer) filed 13 Form 4 reports in the trailing twelve months (0 purchases, 13 sales), most often in Nurix Therapeutics, Inc. (NRIX). The largest single filing was $642K of NRIX (37,600 sh × $17.07, as filed), executed Nov 24 2025. Data as of Nov 8 2026.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
–
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
–
returns measure stock purchases only
Filings, ttm
13
0 buys · 13 sells
Median delay
–
measured on stock purchases
Volume, ttmiDollar value disclosed in the trailing twelve months
$2.8M
shares × price, as filed
Last traded
Nov 3
Filed Nov 4
Median ADV $54.4M across their filed names
Open performance→Volume by month
Buys $0
Sells $3.8M
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Healthcare
13 filings
Sector per market data · by filing · past 12 months
Most traded names
NRIXRecent filings
NRIXSALE
Nurix Therapeutics, Inc.
View filing →
$403K15,640 sh across 2 lots
Exec Nov 2
Filed Nov 4 · 5:03 PM ET NRIXSALE Nurix Therapeutics, Inc. View filing → $104K
3,957 sh × $26.28
Exec Oct 30
Filed Nov 2 · 7:44 PM ET NRIXSALE Nurix Therapeutics, Inc. View filing → $134K
5,786 sh × $23.19
Exec Oct 2
Filed Oct 2 · 5:21 PM ET NRIXSALE Nurix Therapeutics, Inc. View filing → $138K
5,387 sh × $25.69
Exec Sep 2
Filed Sep 2 · 7:42 PM ET NRIXSALE Nurix Therapeutics, Inc. View filing → $382K
16,589 sh × $23.05
Exec Aug 3
Filed Aug 3 · 5:51 PM ET NRIXSALE Nurix Therapeutics, Inc. View filing → $259K
11,008 sh × $23.56
Exec Jul 2
Filed Jul 2 · 6:02 PM ET NRIXSALE Nurix Therapeutics, Inc. View filing → $580K
28,935 sh × $20.06
Exec Jun 25
Filed Jun 25 · 5:30 PM ET NRIXSALE Nurix Therapeutics, Inc. View filing → $135K
8,148 sh × $16.60
Exec Jun 2
Filed Jun 2 · 5:30 PM ET More filings →